Biotech
AxoSim acquires Vyant’s organoid tech for brain disorder research
Anika Sharma
AxoSim, a New Orleans-based drug discovery biotech, has successfully completed the acquisition of the neuroscience research assets from Vyant Bio’s ...
UK Biotech Sector Thrives with Record venture capital Funding in Q2
SG Tylor
In the face of an economic downturn, the second quarter of the year saw a robust influx of new financing ...
